Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis

Kidney International

Volumn 56, Issue 6, 1999, Pages 2005-2015

  Clark, William R ^a,b,c,d   Hamburger, Richard J ^a,b,c   Lysaght, Michael J ^a,b,c  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

Acute renal failure; Biocompatibility; Cellulosic dialysis membranes; End stage renal disease; Hemofiltration; Synthetic dialysis membranes; Water flux

Indexed keywords

ACRYLONITRILE; BETA 2 MICROGLOBULIN; BIOMATERIAL; CELLULOSE; CUPROPHANE; CYANOCOBALAMIN; HYDROXYL GROUP; M PROTEIN;

ACUTE KIDNEY FAILURE; BIOCOMPATIBILITY; DEVICE; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMOFILTRATION; MEMBRANE COMPONENT; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0033456219     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00784.x     Document Type: Article

References (84)

1. 1. Patel R, Vertes V, Bloomfield D, Levy M: Improvements in use of the twin-coil kidney for chronic dialysis in a large center. Trans Am Soc Artif Intern Organs 13:5-9, 1967
2. 2. Pollard TL, Barnet BMS, Eschbach JW. Scribner BW: A technique for the storage and multiple re-use of the Kiil dialyzer and blood tubing. Trans Am Soc Artif Intern Organs 13:24-28, 1967
3. 3. Tsaltas TT: Comparison of various methods of dialysis: Subjective experiences and laboratory data. Trans Am Soc Artif Intern Organs 13:29-32, 1967
4. 4. Lysaght MJ: Evolution of hemodialysis membranes. Contrib Nephrol 113:1-10, 1995
5. 5. Lipps B, Stewart R, Perkins H, Holmes G, McLain E, Rolfs M, Oja P: The hollow fiber artificial kidney. Trans Am Soc Artif Intern Organs 13:200-207, 1967
6. 6. Lysaght MJ: Hemodialysis membranes in transition. Contrib Nephrol 61:1-17, 1988
7. 7. Akizawa T, Kinugasa E, Ideura T: Classification of dialysis membranes by performance. Contrib Nephrol 113:25-31, 1995
8. 8. Henderson L: Biophysics of ultrafiltration and hemofiltration, in Replacement of Renal Function by Dialysis (4th ed), edited by Jacobs C, Kjellstrand C, Koch K, Winchester J, Dordrecht, Kluwer Academic Publishers, 1996, pp 114-145
9. 9. Miller J, Shinaberger J, Henderson L, Gardner P: In vivo analysis of the Lundia (PRO 5) and Lundia (PRO 3) dialyzers with Gambrane polycarbonate membranes. Blood Purif 4:63-73, 1986
10. 10. Van Stone J: Hemodialysis apparatus, in Handbook of Dialysis (2nd ed), edited by Daugirdas J, Ing T, Boston, Little, Brown, 1994, pp 30-52
11. 11. Kaiser J, Hagemann J, Von Herrath D, Schaefer K: Different handling of beta2-microglobulin during hemodialysis and hemofiltration. Nephron 48:132-135, 1988
12. 12. Ward R, Buscaroli A, Schmidt B, Stefoni S, Gurland H, Klinkmann H: A comparison of dialysers with low-flux membranes: Significant differences in spite of many similarities. Nephrol Dial Transplant 12:965-972, 1997
13. 13. Cheung A, Agodoa L, Daugirdas J, Depner T, Gotch F, Greene T, Levin N, Leypoldt JK: Effects of hemodialyzer reuse on clearances of urea and β2-microglobulin. J Am Soc Nephrol 10:117-127, 1999
14. 14. Keshaviah P, Luehmann D, Ilstrup K, Collins A: Technical requirements for rapid high efficiency therapies. Artif Organs 110:189-194, 1986
15. 15. Walton D, Cheung A: Membrane biocompatibility, in Clinical Dialysis (3rd ed), edited by Nissenson A, Fine R, Gentile D, Norwalk, CT, Appleton and Lange, 1995, pp 93-120
16. 16. Grooteman M, Nube M, van Limbeek J, van Houte A, Daha M, van Geelen J: Biocompatibility and performance of a modified cellulosic and a synthetic high-flux dialyzer. ASAIO J 41:215-220, 1995
17. 17. Grooteman M, Nube M, Daha M, Van Limbeek J, Van Deuren M, Schoorl M, Bet P, Van Houte A: Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol 8:1745-1754, 1997
18. 18. Hoenich NA, Woffindin C, Matthews JNS, Goldfinch ME, Turnbull J: Clinical comparison of high-flux cellulose acetate and synthetic membranes. Nephrol Dial Transplant 9:60-66, 1994
19. 19. Schaefer R, Horl W, Kokot K, Heidland A: Enhanced biocompatibility with a new cellulosic membrane: Cuprophan vs hemophan. Blood Purif 5:262-267, 1987
20. 20. Lucchi L, Bonucchi D, Acerbi M: Improved biocompatibility by modified cellulose membranes: The case of Hemophan. Artif Organs 13:417-421, 1989
21. 21. Bowry S, Rintelen T: Synthetically modified cellulose: A cellulosic hemodialysis membrane with minimized complement activation. ASAIO J 44:M579-M583, 1998
22. 22. Pascual M, Steiger G, Estreicher J, Macon K, Volankis J, Schifferli J: Metabolism of complement factor D in renal failure. Kidney Int 34:529-536, 1988
23. 23. Rauterberg E, Ritz E: Bioincompatibility of dialysis membranes: Factor H binding correlates inversely with complement activation indicating a local imbalance of involved proteases/anti-proteases. Adv Exp Med Biol 240:365-375, 1992
24. 24. Pascual M, Schifferli J: Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 43:903-911, 1993
25. 25. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buonchristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 54:580-589, 1998
26. 26. Deppisch R, Gohl H, Smeby L: Microdomain structure of polymeric surfaces: Potential for improving blood treatment procedures. Nephrol Dial Transplant 13:1354-1359, 1998
27. 27. Lane D, Bowry S: The scientific basis for selection of measures of thrombogenicity. Nephrol Dial Transplant 9(Suppl 2):18-28, 1993
28. 28. Craddock P, Fehr J, Dalmasso A, Brigham K, Jacob H: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59:879-888, 1977
29. 29. Hakim R, Fearon D, Lazarus JM: Biocompatiblity of dialysis membranes: Effects of chronic complement activation. Kidney Int 26:194-200, 1984
30. 30. Hoenich N, Woffindin C, Ronco C: Haemodialysers and associated devices, in Replacement of Renal Function by Dialysis (4th ed), edited by Jacobs C, Kjellstrand C, Koch K, Winchester J, Dordrecht, Kluwer Academic, 1996, pp 188-230
31. 31. Jorstad S, Smeby L, Balstad T, Wideroe T: Removal, generation, and adsorption of beta-2-microglobulin during hemofiltration with five different membranes. Blood Purif 6:96-105, 1988
32. 32. Ingram A, Parbtani A, Churchill D: Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins: A cross-over trial. Nephrol Dial Transplant 13:1452-1457, 1998
33. 33. Lonneman G, Schindler R, Luftt V, Mahiout A, Shaldon S, Koch KM: The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Nephrol Dial Transplant 10:207-211, 1995
34. 34. Hoenich N, Woffindin C, Cox P, Goldfinch M, Roberts S: Clinical characterization of Dicea: A new cellulose membrane for haemodialysis. Clin Nephrol 48:253-259, 1997
35. 35. Murthy B, Sundaram S, Jaber B, Perrella C, Meyer K, Pereira B: Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. J Am Soc Nephrol 9:464-472, 1998
36. 36. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D: Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int 30:429-432, 1986
37. 37. Gohl H, Buck R, Strathmann H: Basic features of polyamide membranes. Contrib Nephrol 96:1-25, 1992
38. 38. Piazolo P, Brech W, Niedermayer W, Albrecht J, Hennemann H, Witter E: Clinical multicenter study of Hemoflow F6 in comparison with different standard dialyzers. Contrib Nephrol 74:22-33, 1989
39. 39. Ronco C, Scabardi M, Goldoni M, Brendolan A, Crepaldi C, LaGreca G: Impact of spacing filaments external to hollow fibers on dialysate flow distribution and dialyzer performance. Int J Artif Organs 20:261-266, 1997
40. 40. Leypoldt JK, Cheung A, Agodoa L, Daugirdas J, Greene T, Keshaviah P: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. Kidney Int 51:2013-2017, 1997
41. 41. Nolph K, Nothum R, Maher J: Ultrafiltration: A mechanism for removal of intermediate molecular weight substances in coil dialyzers. Kidney Int 6:55-60, 1974
42. 42. Anderstam B, Mamoun A, Sodersten P, Bergstrom J: Middlesized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 7:2453-2460, 1996
43. 43. Agarwal R, Cronin R: Heterogeneity of gentamicin clearance between high-efficiency hemodialyzers. Am J Kidney Dis 23:47-51, 1994
44. 44. Thalhammer F, Kletzmayr J, El Menyawi I, Kovarik J, Rosenkranz A, Traunmuller F, Horl W, Burgmann H: Ofloxacin clearance during hemodialysis: A comparison of polysulfone and cellulose acetate hemodialyzers. Am J Kidney Dis 32:642-645, 1998
45. 45. Scott M, Mueller B, Clark W: Vancomycin mass transfer characteristics of high-flux cellulosic dialysers. Nephrol Dial Transplant 12:2647-2653, 1997
46. 46. Tan C, Lee H, Ti T, Lee E: Pharmacokinetics of intravenous vancomycin in patients with end-stage renal disease. Ther Drug Monit 12:29-34, 1990
47. 47. Rodvold K, Blum R, Fischer J: Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 32:848-852, 1988
48. 48. Scott M, Mueller B, Clark W: Dialyzer dependent changes in solute and water permeability with bleach reprocessing. Am J Kidney Dis 33:87-96, 1999
49. 49. Colton C, Henderson L, Ford C, Lysaght M: Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow fiber blood ultrafilter. J Lab Clin Med 85:355-371, 1975
50. 50. Henderson L, Colton C, Ford C: Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 85:372-391, 1975
51. 51. Ledebo I: Principles and practice of hemofiltration and hemodiafiltration. Artif Organs 22:20-25, 1998
52. 52. Jindal KK, McDougall J, Woods B, Nowakowski L, Goldstein MB: A study of the basic principles determining the performance of several high-flux dialyzers. Am J Kidney Dis 14:507-511, 1989
53. 53. Zingraff J, Beyne P, Urena P, Uzan M, Nguyen K, Descamps-Latscha B, Drueke T: Influence of haemodialysis membranes on beta2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant 3:284-290, 1988
54. 54. Kaiser J, Hagemann J, Von Herrath D, Schaefer K: Different handling of beta2-microglobulin during hemodialysis and hemofiltration. Nephron 48:132-135, 1988
55. 55. Goldman M, Lamiche M, Dhaene M, Amraoui Z, Thayse C, Vanherweghem J: Adsorption of beta2-microglobulin on dialysis membranes: Comparison of different dialyzers and effects of reuse. Int J Artif Organs 12:373-378, 1989
56. 56. Klinke B, Rockel A, Abdelhamid S, Fiegel P, Walb D: Transmembrane transport and adsorption of beta2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate, and cuprammonium rayon membranes. Int J Artif Organs 12:697-702, 1989
57. 57. Floege J, Granolleras C, Bingel M, Deschodt G, Branger B, Oules R, Shaldon S, Koch K: Beta2-microglobulin kinetics during hemodialysis and hemofiltration. Nephrol Dial Transplant 1:223-228, 1987
58. 58. Floege J, Granolleras C, Deschodt G, Heck M, Baudin G, Branger B, Tournier O, Reinhard B, Eisenbach G, Smeby L, Koch K, Shaldon S: High-flux synthetic vs cellulosic membranes for beta2-microglobulin removal during hemodialysis, hemodiafiltration, and hemofiltration. Nephrol Dial Transplant 4:653-657, 1989
59. 59. Jorstad S, Smeby L, Balstad T, Wideroe J: Removal, generation, and adsorption of beta2-microglobulin during hemofiltration with five different membranes. Blood Purif 6:96-105, 1988
60. 60. Floege J, Wilks M, Shaldon S, Koch K, Smeby L: Beta2-microglobulin kinetics during hemofiltration. Nephrol Dial Transplant 3:784-789, 1988
61. 61. Naitoh A, Tatsuguchi T, Okada M, Ohmura T, Sakai K: Removal of beta2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes. Trans Am Soc Artif Intern Organs 34:630-634, 1988
62. 62. Mineshama M, Hoshino T, Era K, Kitano Y, Suzuki T, Sanaka T, Teraoka S, Ahishi T, Ota K: Difference in beta2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers. Trans Am Soc Artif Intern Organs 36:M643-M646, 1990
63. 63. Ronco C, Heifetz A, Fox K, Curtin C, Brendolan A, Gastaldon F, Crepaldi C, Fortunato A, Piertibasi G, Caberlotto A, Brunello A, Milan Manani S, Zanella M, La Greca G: Beta2-microglobulin removal by synthetic dialysis membranes: Mechanisms and kinetics of the molecule. Int J Artif Organs 20:136-143, 1997
64. 64. Clark WR, Macias WL, Molitoris BA, WANG NHL: Membrane adsorption of beta2-microglobulin: Equilibrium and kinetic characterization. Kidney Int 46:1140-1146, 1994
65. 65. Andrade J: Principles of protein adsorption, in Surface and Interfacial Aspects of Biomedical Polymers (vol 2, Protein Adsorption), edited by Andrade J, New York, Plenum Press, 1985
66. 66. Clark WR, Macias WL, Molitoris A, Wang NHL: Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 48:481-488, 1995
67. 67. Cheung AK, Parker C, Wilcox L, Janatova J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 37:1055-1059, 1990
68. 68. Gotch F: Kinetic modeling in hemodialysis, in Clinical Dialysis (3rd ed), edited by Nissenson A, Fine R, Gentile D, Norwalk, Appleton and Lange, 1995, pp 156-158
69. 69. Cohen G, Haag-Weber M, Horl W: Immune dysfunction in uremia. Kidney Int 52(Suppl 62):S79-S82, 1997
70. 70. Haag-Weber M, Mai B, Cohen G, Horl W: Isolation of a granulocyte inhibitory protein from uraemic patients with homology of beta2-microglobulin. Nephrol Dial Transplant 9:382-388, 1994
71. 71. Lonneman G: Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens. Kidney Int 43(Suppl 41):S195-S200, 1993
72. 72. Favero M, Petersen N, Boyer K, Carson L, Bond W: Microbial contamination of renal dialysis systems and associated health risks. Trans ASAIO 20:175-183, 1974
73. 73. Harding G, Klein E, Pass T, Wright R, Million C: Endotoxin and bacterial contamination of dialysis center water and dialysate: A cross-sectional survey. Int J Artif Organs 13:39-43, 1990
74. 74. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro hemodialysis. Nephrol Dial Transplant 7:16-28, 1992
75. 75. Lonneman G, Bingel M, Floege J, Koch K, Shaldon S, Dinarello C: Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kidney Int 33:29-35, 1988
76. 76. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello C: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37:85-93, 1990
77. 77. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine M, Haeffner-Cavaillon N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins. Kidney Int 38:1089-1094, 1990
78. 78. Pereira B: Cytokine production in patients on dialysis. Blood Purif 13:135-146, 1995
79. 79. Goldfarb S, Golper T: Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5:228-232, 1994
80. 80. Muller T, Seitz M, Eckle I, Lange H, Kolb G: Biocompatibility differences with respect to the dialyzer sterilization mode. Nephron 78:139-142, 1998
81. 81. Deppisch R, Schmitt V, Bommer J, Hansch G, Ritz E, Rauterberg E: Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int 37:696-706, 1990
82. 82. Volanakis J, Barnum S, Giddens M, Galla J: Renal filtration and catabolism of complement protein D. N Engl J Med 312:395-399, 1985
83. 83. Deppisch R, Ritz E, Hansch G, Schols M, Rauterberg E: Biocompatibility: Perspectives in 1993. Kidney Int 45(Suppl 44):S77-S84, 1994
84. 84. Kaiser J, Opperman M, Gotze O, Deppisch R, Gohl H, Asmus G, Rohricht B, von Herrath D, Schaefer K: Significant reduction of factor D and immunosuppressive complement fragment Ba by haemofiltration. Blood Purif 13:314-321, 1995